{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:40:38Z","timestamp":1794343238156,"version":"4.9.0"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>Maternal vaccines during pregnancy offer crucial protection against infections for both the pregnant person and their newborn. Vaccines against influenza, pertussis, coronavirus disease 2019, and respiratory syncytial virus are routinely recommended by the Centers for Disease Control and Prevention to safeguard pregnant women and their infants from potentially severe complications. Administering these vaccines during pregnancy helps transfer protective antibodies from the mother to the baby, enhancing immunity during the vulnerable early months of life. Extensive research supports the safety and efficacy of maternal vaccines, with numerous studies demonstrating their protective benefits for both pregnant people and newborns.<\/jats:p>","DOI":"10.1097\/grf.0000000000000882","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:01:40Z","timestamp":1718888500000},"page":"605-619","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Maternal Immunizations: Past, Present, and Future"],"prefix":"10.1097","volume":"67","author":[{"given":"Anne-Marie","family":"Rick","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of General Academic Pediatrics, University of Pittsburgh School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Beigi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences University of Pittsburgh School of Medicine"},{"name":"UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/AOG.0000000000005479","article-title":"Influenza in pregnancy: prevention and treatment: ACOG Committee Statement No. 7","volume":"143","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/AOG.0000000000002301","article-title":"Committee opinion no. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/ijms17060894","article-title":"Dismantling the taboo against vaccines in pregnancy","volume":"17","author":"de Martino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15585\/mmwr.mm7301a3","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2024","volume":"73","author":"Murthy","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","article-title":"Maternal vaccination: a review of current evidence and recommendations","volume":"226","author":"Etti","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","volume":"177","author":"Skoff","year":"2023","journal-title":"JAMA Pediatrics"},{"issue":"suppl 1","key":"R10-20250512","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/jit491","article-title":"Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge","volume":"209","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/cid\/cit934","article-title":"The pertussis problem","volume":"58","author":"Plotkin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.290.22.2968","article-title":"Trends in pertussis among infants in the United States, 1980-1999","volume":"290","author":"Tanaka","year":"2003","journal-title":"JAMA"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1542\/peds.2004-2759","article-title":"Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001","volume":"116","author":"Bisgard","year":"2005","journal-title":"Pediatrics"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2019.11.069","article-title":"Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study","volume":"38","author":"Mack","year":"2020","journal-title":"Vaccine"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/INF.0b013e3182a09b6a","article-title":"Immune responses in infants whose mothers received Tdap vaccine during pregnancy","volume":"32","author":"Hardy-Fairbanks","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/INF.0b013e3182093814","article-title":"Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants","volume":"30","author":"Leuridan","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recommend Rep"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 4","key":"R21-20250512","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1093\/cid\/ciw528","article-title":"An assessment of the cocooning strategy for preventing infant pertussis-United States, 2011","volume":"63","author":"Blain","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"e2023062664","DOI":"10.1542\/peds.2023-062664","article-title":"Maternal pertussis vaccination, infant immunization, and risk of pertussis","volume":"152","author":"Regan","year":"2023","journal-title":"Pediatrics"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciw633","article-title":"Effectiveness of prenatal tetanus, diphtheria, and acellular pertussis vaccination on pertussis severity in infants","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2019.15577","article-title":"Trends in infant pertussis hospitalizations in the United States, 2009-2017","volume":"322","author":"Boulet","year":"2019","journal-title":"JAMA"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7239a4","article-title":"Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women - United States, April 2023","volume":"72","author":"Razzaghi","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"237.e1","DOI":"10.1016\/j.ajog.2016.03.002","article-title":"The optimal gestation for pertussis vaccination during pregnancy:\u00a0a\u00a0prospective cohort study","volume":"215","author":"Naidu","year":"2016","journal-title":"Am J Obstetr Gynecol"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/cis923","article-title":"Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants","volume":"56","author":"Healy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AOG.0000000000001888","article-title":"Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review","volume":"129","author":"McMillan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2015.12790","article-title":"Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations","volume":"314","author":"Sukumaran","year":"2015","journal-title":"JAMA"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"Jama"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","article-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies","volume":"35","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12879-019-4318-3","article-title":"Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis","volume":"19","author":"Mertz","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","article-title":"Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women","volume":"115","author":"Creanga","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/1471-0528.14143","article-title":"Maternal influenza and birth outcomes: systematic review of comparative studies","volume":"124","author":"Fell","year":"2017","journal-title":"BJOG"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The underrecognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1056\/NEJMoa051721","article-title":"Influenza-associated deaths among children in the United States, 2003-2004","volume":"353","author":"Bhat","year":"2005","journal-title":"N Engl J Med"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"634","DOI":"10.15585\/mmwr.mm6722a4","article-title":"Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine","volume":"67","author":"Garten","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R48-20250512","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) - United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R49-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recommend Rep"},{"key":"R50-20250512","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.vaccine.2015.04.063","article-title":"Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1) pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness","volume":"33","author":"Fu","year":"2015","journal-title":"Vaccine"},{"key":"R51-20250512","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/INF.0000000000001006","article-title":"Influenza vaccine effectiveness for fully and partially vaccinated children 6 months to 8 years old during 2011-2012 and 2012-2013: the importance of two priming doses","volume":"35","author":"Thompson","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"RR08","key":"R52-20250512","first-page":"1","article-title":"Prevention and control of influenza","volume":"52","author":"Bridges CBH","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R53-20250512","first-page":"461","article-title":"Vaccines against influenza WHO position paper \u2014 November 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"R55-20250512","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cid\/cit750","article-title":"Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010\u20132011 and 2011\u20132012 influenza seasons","volume":"58","author":"Thompson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R56-20250512","first-page":"CD009982","article-title":"Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes","author":"Salam","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-20250512","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.vaccine.2017.08.037","article-title":"Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group","volume":"35","author":"Fell","year":"2017","journal-title":"Vaccine"},{"key":"R58-20250512","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/21645515.2017.1345385","article-title":"Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis","volume":"14","author":"Nunes","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"R59-20250512","doi-asserted-by":"crossref","first-page":"ofac552","DOI":"10.1093\/ofid\/ofac552","article-title":"Effectiveness of influenza vaccination of pregnant women for prevention of maternal and early infant influenza-associated hospitalizations in South Africa: a prospective test-negative study","volume":"9","author":"Nunes","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R60-20250512","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/irv.12649","article-title":"Optimal timing of influenza vaccine during pregnancy: a systematic review and meta-analysis","volume":"13","author":"Cuningham","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"R61-20250512","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.vaccine.2018.05.117","article-title":"Declining responsiveness to influenza vaccination with progression of human pregnancy","volume":"36","author":"Schlaudecker","year":"2018","journal-title":"Vaccine"},{"key":"R62-20250512","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/infdis\/jis592","article-title":"Pregnancy modifies the antibody response to trivalent influenza immunization","volume":"206","author":"Schlaudecker","year":"2012","journal-title":"J Infect Dis"},{"key":"R63-20250512","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapediatrics.2023.5639","article-title":"Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants","volume":"178","author":"Sahni","year":"2024","journal-title":"JAMA Pediatrics"},{"key":"R64-20250512","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/ciy090","article-title":"Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal","volume":"67","author":"Katz","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R65-20250512","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"key":"R66-20250512","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-016-0482-1","article-title":"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010-May 2016","volume":"40","author":"Moro","year":"2017","journal-title":"Drug Saf"},{"key":"R67-20250512","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1016\/j.vaccine.2019.09.035","article-title":"Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012\u201313, 2013\u201314, and 2014\u201315","volume":"37","author":"Donahue","year":"2019","journal-title":"Vaccine"},{"key":"R68-20250512","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R69-20250512","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R70-20250512","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/AOG.0000000000004166","article-title":"Evaluating the association of stillbirths after maternal vaccination in the vaccine safety datalink","volume":"136","author":"Panagiotakopoulos","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R71-20250512","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.15585\/mmwr.mm6939a2","article-title":"Influenza and tdap vaccination coverage among pregnant women - United States, April 2020","volume":"69","author":"Razzaghi","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R72-20250512","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R73-20250512","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.3390\/ijerph18115613","article-title":"The differences in clinical presentation, management, and prognosis of laboratory-confirmed COVID-19 between pregnant and non-pregnant women: a systematic review and meta-analysis","volume":"18","author":"Khan","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R74-20250512","doi-asserted-by":"crossref","first-page":"769","DOI":"10.15585\/mmwr.mm6925a1","article-title":"Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020","volume":"69","author":"Ellington","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 1","key":"R75-20250512","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/ciab432","article-title":"Risk factors for illness severity among pregnant women with confirmed severe acute respiratory syndrome coronavirus 2 infection\u2014surveillance for emerging threats to mothers and babies network, 22 State, Local, and Territorial Health Departments, 29 March 2020\u20135 March 2021","volume":"73","author":"Galang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R76-20250512","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/AOG.0000000000004339","article-title":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)","volume":"137","author":"Metz","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R78-20250512","doi-asserted-by":"crossref","first-page":"303.e1","DOI":"10.1016\/j.ajog.2021.03.023","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study","volume":"225","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R79-20250512","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0000000000004438","article-title":"Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood","volume":"138","author":"Prabhu","year":"2021","journal-title":"Obstetr Gynecol"},{"key":"R80-20250512","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron Variant from Previous SARS-CoV-2 Infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"R81-20250512","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1016\/j.vaccine.2023.06.032","article-title":"COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn","volume":"41","author":"Munoz","year":"2023","journal-title":"Vaccine"},{"key":"R82-20250512","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat Med"},{"key":"R83-20250512","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.2021.11035","article-title":"Association Between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women","volume":"326","author":"Goldshtein","year":"2021","journal-title":"JAMA"},{"key":"R84-20250512","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Eng J Med"},{"key":"R85-20250512","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2021.15494","article-title":"Spontaneous abortion following COVID-19 vaccination during pregnancy","volume":"326","author":"Kharbanda","year":"2021","journal-title":"JAMA"},{"key":"R86-20250512","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15585\/mmwr.mm7101e1","article-title":"Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021","volume":"71","author":"Lipkind","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R87-20250512","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamapediatrics.2022.0164","article-title":"Association of COVID-19 vaccination during early pregnancy with risk of congenital fetal anomalies","volume":"176","author":"Ruderman","year":"2022","journal-title":"JAMA Pediatrics"},{"key":"R89-20250512","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for COVID-19 among infants","volume":"387","author":"Halasa","year":"2022","journal-title":"N Engl J Med"},{"key":"R90-20250512","doi-asserted-by":"crossref","first-page":"e2023064252","DOI":"10.1542\/peds.2023-064252","article-title":"Maternal COVID-19 vaccination and prevention of symptomatic infection in infants","volume":"153","author":"Cardemil","year":"2024","journal-title":"Pediatrics"},{"key":"R91-20250512","doi-asserted-by":"crossref","first-page":"e0287103","DOI":"10.1371\/journal.pone.0287103","article-title":"Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies","volume":"18","author":"Rick","year":"2023","journal-title":"PLoS ONE"},{"key":"R92-20250512","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/08903344211018185","article-title":"Antibodies against SARS-CoV-2 in human milk: milk conversion rates in the Netherlands","volume":"37","author":"Juncker","year":"2021","journal-title":"J Human Lact"},{"key":"R93-20250512","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"R94-20250512","doi-asserted-by":"crossref","first-page":"e20193611","DOI":"10.1542\/peds.2019-3611","article-title":"Respiratory syncytial virus-associated hospitalizations among young children: 2015-2016","volume":"146","author":"Rha","year":"2020","journal-title":"Pediatrics"},{"key":"R95-20250512","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/j.vaccine.2022.05.077","article-title":"Estimating the burden of adult hospitalized RSV infection including special populations","volume":"40","author":"Nowalk","year":"2022","journal-title":"Vaccine"},{"key":"R96-20250512","first-page":"Cd013757","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"11","author":"Garegnani","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R99-20250512","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R100-20250512","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Eng J Med"},{"key":"R101-20250512","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"key":"R103-20250512","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion f vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"suppl 4)","key":"R105-20250512","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R106-20250512","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.2014-1173","article-title":"Hearing loss and congenital CMV infection: a systematic review","volume":"134","author":"Goderis","year":"2014","journal-title":"Pediatrics"},{"key":"R107-20250512","doi-asserted-by":"crossref","first-page":"e00030","DOI":"10.1128\/JVI.00030-18","article-title":"Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections","volume":"92","author":"Permar","year":"2018","journal-title":"J Virol"},{"key":"R108-20250512","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"R109-20250512","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"R110-20250512","first-page":"jiad593","article-title":"Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB\/MF59 vaccine","author":"Hu","year":"2024","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"R111-20250512","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R112-20250512","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"suppl 2","key":"R113-20250512","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal disease with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R114-20250512","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recommend Rep"},{"key":"R115-20250512","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatrics"},{"key":"R116-20250512","doi-asserted-by":"crossref","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","article-title":"Management of infants at risk for group B streptococcal disease","volume":"144","author":"Puopolo","year":"2019","journal-title":"Pediatrics"},{"issue":"49 pt B","key":"R117-20250512","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.vaccine.2017.07.108","article-title":"Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa","volume":"35","author":"Russell","year":"2017","journal-title":"Vaccine"},{"key":"R118-20250512","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1016\/j.vaccine.2018.09.058","article-title":"Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: a modelling study","volume":"36","author":"Giorgakoudi","year":"2018","journal-title":"Vaccine"},{"key":"R119-20250512","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiz062","article-title":"A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization","volume":"220","author":"Buurman","year":"2019","journal-title":"J Infect Dis"},{"key":"R120-20250512","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N Engl J Med"},{"key":"R121-20250512","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial","volume":"38","author":"Swamy","year":"2020","journal-title":"Vaccine"},{"key":"R122-20250512","first-page":"229","article-title":"Strategies to prevent early and late-onset group B streptococcal infection via interventions in pregnancy","volume":"12","author":"Delara","year":"2023","journal-title":"Pathogens (Basel, Switzerland)"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:15:50Z","timestamp":1747062950000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000882","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}